These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34321716)

  • 1. Evaluation of Five International HBV Treatment Guidelines: Recommendation for Resource-Limited Developing Countries Based on the National Study in Nepal.
    Khadka S; Pandit R; Dhital S; Baniya JB; Tiwari S; Shrestha B; Pandit S; Sato F; Fujita M; Sharma M; Tsunoda I; Mishra SK
    Pathophysiology; 2020 Dec; 27(1):3-13. PubMed ID: 34321716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
    Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
    BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
    Shimakawa Y; Njie R; Ndow G; Vray M; Mbaye PS; Bonnard P; Sombié R; Nana J; Leroy V; Bottero J; Ingiliz P; Post G; Sanneh B; Baldeh I; Suso P; Ceesay A; Jeng A; Njai HF; Nayagam S; D'Alessandro U; Chemin I; Mendy M; Thursz M; Lemoine M
    J Hepatol; 2018 Oct; 69(4):776-784. PubMed ID: 30104154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
    Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
    Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection.
    Assal A; Mackie D; Cooper CL
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1010-4. PubMed ID: 25051218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on guidelines in determining HBV phases in Iranian patients.
    Ashtari S; Sharifian A; Hatami B; Mohebbi SR; Nouri G; Bazdar M; Naderi N
    Gastroenterol Hepatol Bed Bench; 2019; 12(Suppl1):S145-S148. PubMed ID: 32099615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.
    Tufon KA; Meriki HD; Anong DN; Mbunkah HA; Nkuo-Akenji T
    BMC Res Notes; 2016 Feb; 9():117. PubMed ID: 26899506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
    Helaly GF
    Br J Biomed Sci; 2011; 68(1):38-42. PubMed ID: 21473261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection.
    Barut S; Gemici Ü; Güneş F; Demir O; Duygu F
    J Med Virol; 2017 Nov; 89(11):1952-1957. PubMed ID: 28618019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of chronic hepatitis B: Clinical aspects and future directions.
    Zhu M; Wang H; Lou T; Xiong P; Zhang J; Li L; Sun Y; Wu Y
    Front Microbiol; 2022; 13():975584. PubMed ID: 36160238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B: Who to treat? A critical review of international guidelines.
    Huang DQ; Lim SG
    Liver Int; 2020 Feb; 40 Suppl 1():5-14. PubMed ID: 32077616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load].
    Huang X; Yao L; Deng ZR; Dong J; Zheng RJ; Lu XB; Zhang YX; Sun LH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):227-233. PubMed ID: 33902189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.